Literature DB >> 6756719

IgA, IgM and IgG anti-M. leprae antibodies in babies of leprosy mothers during the first 2 years of life.

R Melsom, M Harboe, M E Duncan.   

Abstract

IgA, IgM and IgG anti-M. leprae antibody activity was estimated by solid phase radioimmunoassay in repeated serum samples from cord sera to sera taken 2 years after birth from 29 babies of mothers with lepromatous leprosy (Group 1) and 16 babies of mothers with tuberculoid leprosy and non-leprosy control mothers (Group 2). IgA anti-M. leprae antibody activity could be detected in 30% and IgM anti-M. leprae antibody activity in 50% of cord sera from Group 1, but not in any of the cord sera from Group 2. After birth, there was a significantly higher increase of IgA and IgM anti-M. leprae antibody activity in sera taken 3-6 months after birth from babies of Group 1 compared to Group 2, but the IgA and IgM activity in sera taken after 6 months of age showed the same increase in the two groups. IgG anti-M. leprae antibody activity showed a marked decrease in sera from both Groups 1 and 2 taken 3-6 and 6-9 months after birth compared to the activity in the cord sera. No increase of the IgG activity could be demonstrated even in sera taken 15-24 months after birth in any of the two groups. These findings are discussed in relation to possible transfer of M. leprae bacilli across the placenta, the influence of M. leprae and other mycobacteria exposure on the antibody activity, the poor IgG anti-M. leprae antibody response and subclinical leprosy infection in babies exposed to leprosy below 2 years of age.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6756719      PMCID: PMC1536716     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Antibody activity against Mycobacterium leprae antigen 7 during the first year of DDS treatment in lepromatous (BL-LL) leprosy.

Authors:  R Melsom; B Naafs; M Harboe; O Closs
Journal:  Lepr Rev       Date:  1978-03       Impact factor: 0.537

2.  The continuous bacteremia of lepromatous leprosy.

Authors:  D J Drutz; T S Chen; W H Lu
Journal:  N Engl J Med       Date:  1972-07-27       Impact factor: 91.245

3.  A simplified method for cyanogen bromide activation of agarose for affinity chromatography.

Authors:  S C March; I Parikh; P Cuatrecasas
Journal:  Anal Biochem       Date:  1974-07       Impact factor: 3.365

4.  'Original mycobacterial sin'.

Authors:  E W Abrahams
Journal:  Tubercle       Date:  1970-09

5.  Production of monospecific antisera against antigenic componentsof Mycobacterium bovis (BCG).

Authors:  M Harboe; O Closs; J Deverill
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

6.  Recognition of two distinct groups of human IgM and IgA based on different binding to staphylococci.

Authors:  M Harboe; I Fölling
Journal:  Scand J Immunol       Date:  1974       Impact factor: 3.487

7.  Cell walls of Mycobacterium leprae.

Authors:  P Draper
Journal:  Int J Lepr Other Mycobact Dis       Date:  1976 Jan-Jun

8.  Antigenic analysis of Mycobacterium leprae.

Authors:  O Closs; R N Mshana; M Harboe
Journal:  Scand J Immunol       Date:  1979-03       Impact factor: 3.487

9.  Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland.

Authors:  H Peltola; H Käyhty; A Sivonen; H Mäkelä
Journal:  Pediatrics       Date:  1977-11       Impact factor: 7.124

10.  Antibody response in rabbits to immunization with Mycobacterium leprae.

Authors:  M Harboe; O Closs; B Bjorvatn; G Kronvall; N H Axelsen
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

View more
  1 in total

Review 1.  Current concepts in the pathogenesis of leprosy. Clinical, pathological, immunological and chemotherapeutic aspects.

Authors:  W M Meyers; A M Marty
Journal:  Drugs       Date:  1991-06       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.